A phase 1a, first-in-human, randomized study of a respiratory syncytial virus F protein vaccine with and without a toll-like receptor-4 agonist and stable emulsion adjuvant. - Falloon, Judith; Ji, Fei; Curtis, Craig; Bart, Stephan; Sheldon, Eric; Krieger, Diane; Dubovsky, Filip; Lambert, Stacie; Takas, Therese; Villafana, Tonya; Esser, Mark T. (Vaccine, 2016)